Return |
SUMMARY OF FINDINGS
Opioid vs non-opioid medications for improving pain-related function and reducing pain intensity at 12 months
Outcome at 12 months | Opioid Group | Non-Opioid Group | Effect |
---|---|---|---|
Pain-related function (e.g. walking, house work, sleeping) | 59 out of 100 people had moderate* improvement | 61 out of 100 people had moderate* improvement | None** |
Pain intensity | 41 out of 100 people had moderate* improvement | 54 out of 100 people had moderate* improvement | About 13 more people had moderate* improvement while taking non-opioids compared to taking opioids |
Medication-related adverse effects | People in the opioid group experienced more adverse effects than people in the non-opioid group (details were not provided) |
*moderate = 30% reduction in pain score
**Although the rates for the 2 groups look different, the difference may be due to chance rather than due to the treatments
This was a randomized controlled trial performed in outpatient primary care clinics in the US.
Who? This study included 240 people (average age 58; 36% women) with moderate to severe back pain (65%) or hip or knee osteoarthritis pain (35%) despite taking medication. Pain was rated as moderate to severe based on a score that included pain intensity, interference with enjoyment of life, and inteference with general activity. Pain had to be present nearly every day for at least 6 months.
What? The study compared opioid medication with nonopioid medication on pain-related function at 12 months. Pain-related function = general activity, mood, walking ability, normal work, relations with other people, sleep, enjoyment of life. Patients and their physicians knew which study group they were assigned to, but the people analyzing the results did not know.
Opioid medications | vs | Non-opioid medications |
---|---|---|
Step 1: morphine (short-acting) OR hydrocodone/acetaminophen OR oxycodone (short-acting) Step 2: morphine (long-acting) OR oxycodone (long-acting) Step 3: fentanyl skin patch People moved from one step to another if their pain wasn't improved and after discussion with a study pharmacist | Step 1: acetaminophen and nonsteroidal anti-inflammatory medications Step 2: nortriptyline, amitriptyline, gabapentin and medications applied to the skin (e.g. capsaicin, lidocaine) Step 3: pregabalin, duloxetine and tramadol* People moved from one step to another if their pain wasn't improved and after discussion with a study pharmacist | |
*this medication is considered an opioid |
Opioid medications have been prescribed by doctors to treat chronic pain for many years despite limited evidence to show they work and rising evidence that they can be harmful. Researchers performed this study to find out if opioid medications were better than non-opioid medications for improving pain-related function and reducing pain intensity.
Experts have concerns about the results of this study because only low doses of opioids were used and some patients assigned to the non-opioid group took opioids when they weren’t supposed to. These problems mean a future study might find different results.
This Evidence Summary is based on the following article:
Krebs EE, Gravely A, Nugent S, et al. Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial. JAMA. 2018 Mar 6;319(9):872-882. doi: 10.1001/jama.2018.0899. PubMed
Published: Wednesday, July 1, 2020
Last Updated: Wednesday, December 2, 2020
Please note that the information contained herein is not to be interpreted as an alternative to medical advice from a professional healthcare provider. If you have any questions about any medical matter, you should consult your professional healthcare providers, and should never delay seeking medical advice, disregard medical advice or discontinue medication based on information provided here.
This Evidence Summary was printed from the PAIN+ CPN website on 2024/11/21. To view other Evidence Summaries or to register to receive email notifications about new Evidence Summaries, please visit us at https://www.painpluscpn.ca/Articles/EvidenceSummaries |